FLEBOGAMMADIF 100 MG/ML FL 200 ML
(Immunoglobuline humaine normale) - Maladie rare sans désignation orpheline
* Replacement therapy in adults, and children and adolescents (2-18 years) in:
- Primary immunodeficiency (PID) syndromes with impaired antibody production.
- Hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia, in whom prophylactic antibiotics have failed.
- Hypogammaglobulinaemia and recurrent bacterial infections in plateau phase multiple myeloma patients who have failed to respond to pneumococcal immunisation.
- Hypogammaglobulinaemia in patients after allogeneic haematopoietic stem cell transplantation (HSCT).
* Immunomodulation in adults, and children and adolescents (2-18 years) in:
- Primary immune thrombocytopenia (ITP), in patients at high risk of bleeding or prior to surgery to correct the platelet count.
- Guillain-Barré syndrome,
- Kawasaki disease.